Michael Jeffers

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Nagma Khan, Michael Jeffers, Sampath Kumar et al. · Biochemical Journal · 2007 · 710 citations · Full text

Medicine, Oncology, Pharmacology +10

Activating mutations for the Met tyrosine kinase receptor in human cancer

Michael Jeffers, Laura S. Schmidt, Noboru Nakaigawa et al. · Proceedings of the National Academy of Sciences · 1997 · 440 citations

Medicine, Molecular Biology, Oncology +17

PDGF-D, a new protease-activated growth factor

William J. LaRochelle, Michael Jeffers, William F. McDonald et al. · Nature Cell Biology · 2001 · 416 citations

Life Sciences, Biochemistry, Molecular Biology +9

Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways

Guang‐Hui Xiao, Michael Jeffers, Alfonso Bellacosa et al. · Proceedings of the National Academy of Sciences · 2000 · 396 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Josep Tabernero, Heinz‐Josef Lenz, Salvatore Siena et al. · The Lancet Oncology · 2015 · 326 citations · Full text

Medicine, Molecular Medicine, Oncology +17